Niu J - Search Results

1

Impact of nonalcoholic fatty liver disease status change on antiviral efficacy of nucleos(t)ide analogues in HBeAg-positive chronic hepatitis B.

Tang Y, Fan R, Lan Z, Xie Q, Zhang J, Liang X, Wang H, Tan D, Cheng J, Chen S, Ning Q, Bai X, Xu M, Chen X, Niu J, Shi J, Ren H, Gao Z, Wang M, Dou X, Hou J, Sun J. Tang Y, et al. Among authors: niu j. J Med Virol. 2023 Feb;95(2):e28501. doi: 10.1002/jmv.28501. J Med Virol. 2023. PMID: 36655747 Clinical Trial.

2

[A multicenter, randomized, open-label study of the safety and effectiveness of pegylated interferon alpha 2b and interferon alpha 2b in treating HBeAg positive chronic hepatitis B patients].

Zhao H, Si CW, Wei L, Wan MB, Ying YK, Hou JL, Niu JQ. Zhao H, et al. Zhonghua Gan Zang Bing Za Zhi. 2006 May;14(5):323-6. Zhonghua Gan Zang Bing Za Zhi. 2006. PMID: 16732903 Clinical Trial. Chinese.

3

Genotype B and younger patient age associated with better response to low-dose therapy: a trial with pegylated/nonpegylated interferon-alpha-2b for hepatitis B e antigen-positive patients with chronic hepatitis B in China.

Zhao H, Kurbanov F, Wan MB, Yin YK, Niu JQ, Hou JL, Wei L, Wang GQ, Tanaka Y, Mizokami M, Si CW. Zhao H, et al. Clin Infect Dis. 2007 Feb 15;44(4):541-8. doi: 10.1086/511042. Epub 2007 Jan 11. Clin Infect Dis. 2007. PMID: 17243057 Clinical Trial.

4

[The degree of HBV suppression with 24 week telbivudine- or lamivudine-treatment in hepatitis B patients predicts the efficacy of the treatment at week 52].

Jia JD, Hou JL, Yin YK, Xu DZ, Tan DM, Niu JQ, Zhou XQ, Wang YM, Zhu LM, He YW, Ren H, Wan MB, Chen CW, Wu SM, Chen YG, Xu JZ, Wang QH, Wei L, Ma H. Jia JD, et al. Zhonghua Gan Zang Bing Za Zhi. 2007 May;15(5):342-5. Zhonghua Gan Zang Bing Za Zhi. 2007. PMID: 17524265 Clinical Trial. Chinese.

5

Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial.

Hou J, Yin YK, Xu D, Tan D, Niu J, Zhou X, Wang Y, Zhu L, He Y, Ren H, Wan M, Chen C, Wu S, Chen Y, Xu J, Wang Q, Wei L, Chao G, Constance BF, Harb G, Brown NA, Jia J. Hou J, et al. Among authors: niu j. Hepatology. 2008 Feb;47(2):447-54. doi: 10.1002/hep.22075. Hepatology. 2008. PMID: 18080339 Clinical Trial.

6

A randomized controlled phase IIb trial of antigen-antibody immunogenic complex therapeutic vaccine in chronic hepatitis B patients.

Xu DZ, Zhao K, Guo LM, Li LJ, Xie Q, Ren H, Zhang JM, Xu M, Wang HF, Huang WX, Bai XF, Niu JQ, Liu P, Chen XY, Shen XL, Yuan ZH, Wang XY, Wen YM. Xu DZ, et al. PLoS One. 2008 Jul 2;3(7):e2565. doi: 10.1371/journal.pone.0002565. PLoS One. 2008. PMID: 18596958 Free PMC article. Clinical Trial.

7

Antiviral treatment alters the frequency of activating and inhibitory receptor-expressing natural killer cells in chronic hepatitis B virus infected patients.

Lv J, Jin Q, Sun H, Chi X, Hu X, Yan H, Pan Y, Xiao W, Tian Z, Hou J, Xu D, Tu Z, Niu J. Lv J, et al. Among authors: niu j. Mediators Inflamm. 2012;2012:804043. doi: 10.1155/2012/804043. Epub 2012 Dec 10. Mediators Inflamm. 2012. PMID: 23304062 Free PMC article. Clinical Trial.

8

Distribution and clinical correlates of viral and host genotypes in Chinese patients with chronic hepatitis C virus infection.

Rao H, Wei L, Lopez-Talavera JC, Shang J, Chen H, Li J, Xie Q, Gao Z, Wang L, Wei J, Jiang J, Sun Y, Yang R, Li H, Zhang H, Gong Z, Zhang L, Zhao L, Dou X, Niu J, You H, Chen Z, Ning Q, Gong G, Wu S, Ji W, Mao Q, Tang H, Li S, Wei S, Sun J, Jiang J, Lu L, Jia J, Zhuang H. Rao H, et al. Among authors: niu j. J Gastroenterol Hepatol. 2014 Mar;29(3):545-53. doi: 10.1111/jgh.12398. J Gastroenterol Hepatol. 2014. PMID: 24090188 Free PMC article.

9

The 104-week efficacy and safety of telbivudine-based optimization strategy in chronic hepatitis B patients: a randomized, controlled study.

Sun J, Xie Q, Tan D, Ning Q, Niu J, Bai X, Fan R, Chen S, Cheng J, Yu Y, Wang H, Xu M, Shi G, Wan M, Chen X, Tang H, Sheng J, Dou X, Shi J, Ren H, Wang M, Zhang H, Gao Z, Chen C, Ma H, Jia J, Hou J. Sun J, et al. Among authors: niu j. Hepatology. 2014 Apr;59(4):1283-92. doi: 10.1002/hep.26885. Epub 2014 Feb 28. Hepatology. 2014. PMID: 24382690 Clinical Trial.

10

Randomized, three-arm study to optimize lamivudine efficacy in hepatitis B e antigen-positive chronic hepatitis B patients.

Liang X, Cheng J, Sun Y, Chen X, Li T, Wang H, Jiang J, Chen X, Long H, Tang H, Yu Y, Sheng J, Chen S, Niu J, Ren H, Shi J, Dou X, Wan M, Jiang J, Xie Q, Shi G, Ning Q, Chen C, Tan D, Ma H, Sun J, Jia J, Zhuang H, Hou J. Liang X, et al. Among authors: niu j. J Gastroenterol Hepatol. 2015 Apr;30(4):748-55. doi: 10.1111/jgh.12835. J Gastroenterol Hepatol. 2015. PMID: 25352300 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,633 results

Search Page